本页面由Tiger Trade Technology Pte. Ltd.提供服务

Context Therapeutics Inc.

0.2750
-0.0300-9.84%
盘后:0.28940.0144+5.24%19:42 EDT
成交量:125.41万
成交额:34.84万
市值:2,526.68万
市盈率:-0.57
高:0.3056
开:0.3013
低:0.2700
收:0.3050
52周最高:3.62
52周最低:0.2700
股本:9,187.92万
流通股本:6,373.36万
量比:1.86
换手率:1.97%
股息:- -
股息率:- -
每股收益(TTM):-0.4828
每股收益(LYR):-0.3800
净资产收益率:-76.14%
总资产收益率:-45.70%
市净率:0.66
市盈率(LYR):-0.72

数据加载中...

2024/12/02

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

SEC问询函

Form CORRESP - Correspondence
2024/11/06

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/09/23

重要事件披露

Form 8-K - Current report
2024/09/17

重要事件披露

Form 8-K - Current report
2024/09/04

重要事件披露

Form 8-K - Current report
2024/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/10

重要事件披露

Form 8-K - Current report
2024/06/14

重要事件披露

Form 8-K - Current report
2024/06/05

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/30

SEC问询函

Form CORRESP - Correspondence
2024/05/24

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/10

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/02

重要事件披露

Form 8-K - Current report